{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:12:34Z","timestamp":1760616754285,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.rmed.2019.105855","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:35:23Z","timestamp":1576888523000},"page":"105855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Evaluating S100B as a serum biomarker for central neurosarcoidosis"],"prefix":"10.1016","volume":"162","author":[{"given":"B.P.","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.O.","family":"Tavee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.105855_bib1","first-page":"499","volume":"vol. 38","author":"Culver","year":"2017"},{"issue":"10\u201311","key":"10.1016\/j.rmed.2019.105855_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clinbiochem.2008.04.003","article-title":"Biological and methodological features of the measurement of S100B, a putative marker of brain injury","volume":"41","author":"Gon\u00e7alves","year":"2008","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.rmed.2019.105855_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0404.2010.01393.x","article-title":"Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone","volume":"123","author":"Bartosik\u2010Psujek","year":"2011","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.rmed.2019.105855_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1191\/1352458504ms1021sr","article-title":"Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis","volume":"10","author":"Petzold","year":"2004","journal-title":"Multiple Sclerosis Journal"},{"issue":"2","key":"10.1016\/j.rmed.2019.105855_bib5","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis, vasculitis, and diffuse lung diseases","volume":"16","author":"Hunninghake","year":"1999","journal-title":"official journal of WASOG"},{"issue":"1","key":"10.1016\/j.rmed.2019.105855_bib6","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2019.105855_bib7","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases","volume":"16","author":"Judson","year":"1999","journal-title":"official journal of WASOG"},{"issue":"9","key":"10.1016\/j.rmed.2019.105855_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ\u20109: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.105855_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-5223(00)70229-7","article-title":"Predictive value of S-100\u03b2 and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery","volume":"119","author":"Georgiadis","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"year":"2018","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","key":"10.1016\/j.rmed.2019.105855_bib10"},{"issue":"11","key":"10.1016\/j.rmed.2019.105855_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev. Clin. Immunol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119303695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119303695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:56:26Z","timestamp":1760615786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119303695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":11,"alternative-id":["S0954611119303695"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.105855","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating S100B as a serum biomarker for central neurosarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.105855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105855"}}